文献速递抗菌药物管理特殊人群用药

柔性膀胱镜检查后尿路感染率的评估

Evaluation of post-flexible cystoscopy urinary tract infection rates.
PubMed 文献 · Am J Health Syst Pharm · 2020-01-01

该回顾性研究比较了柔性膀胱镜检查前接受口服抗菌药物预防与未接受预防的患者,发现症状性尿路感染发生率分别为2.2%和2.5%,差异无统计学意义;年龄超过65岁是所有感染患者共有的风险因素。

要点

  • 柔性膀胱镜前预防性使用抗菌药物未显著降低症状性尿路感染率。
  • 年龄超过65岁是膀胱镜后尿路感染患者中唯一共有的风险因素。
  • 膀胱镜后尿路感染发生率低于既往文献报道。

核心结论

  • 柔性膀胱镜检查后症状性尿路感染率较低,预防性抗菌药物使用与未使用组发生率相似。

研究设计与样本

  • 回顾性队列研究,纳入296例门诊柔性膀胱镜检查患者,其中139例未预防用药,157例预防用药(头孢呋辛500mg或复方磺胺甲噁唑800/160mg)。

主要发现

  • 预防用药组与未预防用药组症状性尿路感染发生率分别为2.2%和2.5%(P>0.99)。
  • 符合菌落形成单位指南要求的症状性尿路感染发生率分别为1.4%和1.9%(P>0.99)。
  • 术后因尿路感染接受治疗的比例分别为4.3%和2.5%(P=0.53)。
  • 从检查到开始尿路感染治疗的平均天数为7.9天(范围1-18天)。

关键数值与推荐

  • 预防用药方案为头孢呋辛500mg片剂或复方磺胺甲噁唑800/160mg片剂。
  • 主要结局为柔性膀胱镜检查后30天内症状性尿路感染。

临床怎么用

  • 临床可考虑不常规在柔性膀胱镜检查前使用抗菌药物预防尿路感染。
  • 对年龄超过65岁的患者应加强术后尿路感染监测。

局限性

  • 回顾性研究设计可能引入选择偏倚和信息偏倚。
  • 样本量有限,结论需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The risk of urinary tract infection (UTI) development after flexible cystoscopy (FC) is not well described. It remains difficult to assess the role of pre-FC antimicrobial prophylaxis to reduce UTI risk. METHODS: In fall 2017, the urology service at the Providence Veterans Affairs Medical Center implemented routine oral antimicrobial prophylaxis in its outpatient FC clinic. Outpatients were randomly selected for a retrospective chart review to compare patients who received pre-FC antimicrobials (cefuroxime 500 mg tablet or sulfamethoxazole/trimethoprim [800 mg/160 mg] tablet) and those who underwent FC prior to fall 2017 and did not receive prophylaxis. The primary outcome was presence of symptomatic UTI within 30 days post FC. Secondary outcomes included symptomatic UTI that met colony-forming unit (CFU)/mL guideline requirements, and UTI treatment received. Potential risk factors for UTI were also assessed. RESULTS: A total of 296 patients were included in the final analysis: 139 who did not receive and 157 who received a prophylactic antimicrobial before FC. Rates of symptomatic UTI, symptomatic UTI meeting CFU/mL guideline requirements, and postprocedure treatment for UTI were similar with and without antimicrobial prophylaxis (2.5% vs 2.2% [P > 0.99], 1.9% vs 1.4% [P > 0.99], and 2.5% vs 4.3% [P = 0.53], respectively). The mean number of days from FC to the start of UTI treatment was 7.9 (range, 1-18 days). Age over 65 years was the only risk factor present in all patients with a post-FC UTI, irrespective of antimicrobial prophylaxis. CONCLUSION: The rate of post-FC symptomatic UTI was lower than rates previously described in the literature. The role of antimicrobial prophylaxis prior to FC warrants further exploration.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Cusumano JA, Hermenau M, Gaitanis M, et al. Evaluation of post-flexible cystoscopy urinary tract infection rates. Am J Health Syst Pharm. 2020. PMID: 32827037. doi:10.1093/ajhp/zxaa270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。